Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study

Graham A. Colditz, Meir J. Stampfer, Walter C. Willett, David J. Hunter, Jo Ann E. Manson, Charles H. Hennekens, Bernard A. Rosner, Frank E. Speizer

Research output: Contribution to journalArticle

113 Scopus citations

Abstract

We prospectively examined the use of hormone replacement therapy in relation to breast cancer incidence in a cohort of women 30 to 55 years of age in 1976. During 12 years of follow-up (480,665 person-years) among postmenopausal women, 1,050 incident cases of breast cancer were documented. Overall, past users of replacement estrogen were not at increased risk. After adjustment for established risk factors, type of menopause, age at menopause, and current age, the rate ratio (RR) was 0.91, 95 percent confidence interval (CI) = 0.78-1.07. the risk of breast cancer was elevated significantly among current users (RR = 1.33, CI = 1.12-1.57); after adjusting for age, we observed no evidence of increasing risk with increasing duration of use among current users (P trend = 0.41), or among past users (P trend = 0.46). Women currently using unopposed estrogen (RR = 1.42, CI = 1.19-1.70), estrogen and progesterone (RR = 1.54, CI = 0.99-2.39), or progesterone alone (RR = 2.52, CI = 0.66-9.63), were all at increased risk of breast cancer compared with never users. These data suggest that long-term past use of estrogen replacement therapy is not related to risk, that current estrogen use increases risk of breast cancer to a modest degree, and that the addition of progesterone does not remove the increased risk observed with current use of unopposed estrogen.

Original languageEnglish
Pages (from-to)433-439
Number of pages7
JournalCancer Causes and Control
Volume3
Issue number5
DOIs
StatePublished - Sep 1 1992
Externally publishedYes

Keywords

  • Breast cancer
  • Nurses' Health Study
  • USA
  • cohort study
  • estrogens
  • progestins

Fingerprint Dive into the research topics of 'Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study'. Together they form a unique fingerprint.

  • Cite this

    Colditz, G. A., Stampfer, M. J., Willett, W. C., Hunter, D. J., Manson, J. A. E., Hennekens, C. H., Rosner, B. A., & Speizer, F. E. (1992). Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes and Control, 3(5), 433-439. https://doi.org/10.1007/BF00051356